The challenge of medicines

Slides:



Advertisements
Similar presentations
Consulting on the Telephone OOH GP Training Day. Learning Objectives Review our approach to consulting on the phone Address concerns over this format.
Advertisements

Definitions Patient Experience Patient experience at NUH results from a range of activities that all impact upon patient care, access, safety and outcomes.
Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
Disease State Management The Pharmacist’s Role
The challenge of medicines non-adherence. 2 How is adherence defined? WHO definition: ‘the extent to which a person’s behaviour – taking medication, following.
Lecture 3: Health Psychology and Physical Illnesses I (Part 2)
Building unique support solutions for individual patient needs Visit us: © 2011 Atlantis Healthcare | Commercial in Confidence.
Concordance Monica Arora © Swindon/Bath GPR Day Release Course 2006.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
Patient Compliance With Medical Advice. Patient compliance (patient adherence) :  The extent to which the patient adheres to medical advice Patient compliance.
Clinical Pharmacy Basma Y. Kentab MSc..
Clinical Training: Medication Reconciliation
Following Your Treatment Plan. Taking your medication is an important part of your treatment. 2.
Explanation and planning. What are the objectives of explanation and planning?
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
Pharmacists’ Expanded Scope of Practice in Canada as of Oct 2014 Source: Canadian Pharmacists Association.
Introducing the Medication Recording System Schedule Ed Castagna Mom & Pop’s Small Business Services.
Education & Training Curriculum on Multiple Chronic Conditions (MCC) Strategies & tools to support health professionals caring for people living with MCC.
Medication Adherence The following module is designed as a basic overview of medication adherence for providers of healthcare, particularly those in a.
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
CHESHIRE & MERSEYSIDE PALLIATIVE AND END OF LIFE CLINICAL NETWORK ADVANCE CARE PLANNING FRAMEWORK PROMOTING CONVERSATIONS AND PLANNING YOUR FUTURE CARE.
PHCL 436 Lecture two. Objectives  The role of cognition in influencing adjustment to chronic conditions  What is medication adherence, prevalence, reasons,
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
UNDERSTANDING AND DEFINING QUALITY Quality Academy – Cohort 6 April 8, 2013.
Community Pharmacy Cheshire & Wirral (CPCW) Helen Murphy Chief Executive Officer Community Pharmacy Cheshire and Wirral.
Standard 10: Preventing Falls and Harm from Falls Accrediting Agencies Surveyor Workshop, 13 August 2012.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
Educational solutions for the NHS pharmacy workforce Medicines Optimisation: Helping patients to make the most of medicines Sue Carter Regional Tutor
Better Patient Adherence: Why patients don’t adhere and what we can do about it (maybe) Frank Doyle, PhD RCSI Royal College of Surgeons in Ireland Coláiste.
GB.DRO f, date of preparation: January 2010 Dartford and Gravesham NHS Trust Pharmacy Services in Hospital.
Medicines adherence Implementing NICE guidance 2009 NICE clinical guideline 76.
Documentation in Practice Dept. of Clinical Pharmacy.
Pharmacy White Paper Building on Strengths Delivering the Future Overview.
Dementia NICE quality standard August What this presentation covers Background to quality standards Publication partners Dementia quality standard.
Community Education Promoting Informed Medicine Use.
European Patients’ Academy on Therapeutic Innovation Challenges in Personalised Medicine.
PHARMACEUTICAL GUIDELINES: BASIC PRINCIPLES AND STATUTES.
Learning objectives Review HIV treatment goals
Barriers for implementing drug holidays in ADHD
Dawn Dowding PhD RN VNSNY Professor of Nursing
Judy Phillips, DNP, FNP-BC, AOCN Cancer Care of Western North Carolina
PHARMACIST : A HEALTH CARE PROFESSIONAL
PATIENT COUNSELLING.
Risk Communication in Medicines
Methotrexate in Psoriasis Shared Care Guidelines
Medicines Optimisation
Think Pharmacy Sue Sharpe CEO PSNC.
Opioids Aware A resource for patients and HCPs to support prescribing of opioid medicines for pain Sue Mulvenna CDAO NHSE S SW March 2016.
Prescribing.
Pharmaceutical Care Plan
Introduction to Clinical Pharmacy
Barriers to implementing COPD guidelines for non-medical prescribers: a qualitative interview study Alison Paterson1, Anne Kinnear1, Marion Bennie2, Moira.
Professor Colin P. Bradley University College Cork
Medication Adherence Improve the health of your patients and reduce overall health care costs.
Integrating Clinical Pharmacy into a wider health economy
NHS Community Pharmacy Contractual Framework
Medication Safety Dr. Kanar Hidayat
Professor of Pharmacy Education and CPPE tutor for Portsmouth
Communication Skills Lecture 1-2
Medication Adherence Improve the health of your patients and reduce overall health care costs.
Participants’ Rights Participants of clinical trials have rights, and they are protected under law when participating in clinical trials. The informed.
Innovations from around England that release time for GPs to do more of what only they can do. bit.ly/gpcapacityforum.
Chemotherapy Services in England: Ensuring quality and safety
Enhancing Respiratory Medication Adherence: The Role of Health Care Professionals and Cost-Effectiveness Considerations  Job F.M. van Boven, PharmD, PhD,
Pharmacy practice experience I
Dawn Dowding PhD RN VNSNY Professor of Nursing
Pharmacy practice and the healthcare system Ola Ali Nassr
Medicines in Adult Social Care Care homes & Care at Home
Let’s talk medicines safety
Presentation transcript:

The challenge of medicines non-adherence

How is adherence defined? WHO definition: ‘the extent to which a person’s behaviour – taking medication, following a diet and/or executing lifestyle changes – corresponds with agreed recommendations from a healthcare provider’

Non-adherence includes: Failing to get a first prescription or subsequent repeats dispensed Discontinuing a medicine before the course of therapy is complete Taking more or less of a medicine than prescribed Taking a dose at the wrong time

How big is the problem? Medicines cannot be effective if patients do not use them There are varying estimates on the size of the problem: Between 33% and 50% of medicines for LTCs are not used as recommended 20-30% don’t adhere to regimens that are curative or relieve symptoms 30-40% fail to follow regimens designed to prevent health problems

How big is the problem? US estimates: 11-20% of hospital admissions (30% for the elderly), A&E visits and repeat doctor visits may be due to non-adherence Overall cost of poor adherence, measured in otherwise avoidable medical spending, is as much as $290 billion per year (13% of US healthcare expenditure)

The challenge It is often a hidden problem undisclosed by patients unrecognised by prescribers It has been suggested that increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments Haynes R, McDonald H, Garg A, Montague P. (2002). Interventions for helping patients to follow prescriptions for medications. The Cochrane Database of Systematic Reviews, 2, CD000011.

Adherence rates are lower among people with LTCs (compared to acute conditions)

What are the consequences? Patient consequences sub-optimal management of their condition potential harm resulting from sub-optimal management This represents a failure to translate the technological benefits of new medicines into health gain for individuals

What are the consequences? NHS consequences increased spend to counter sub-optimal patient management sometimes increased clinical risk due to additional prescribing cost of medicines dispensed but not used cost of safe disposal of unwanted medicines

What are the consequences? Societal costs Poorly managed LTCs can reduce the economic contribution individuals can make to society

Why don’t some people use their medicines as prescribed? 1) They don’t want to (intentional non-adherence) 2) They have practical problems (unintentional non-adherence)

Adherence is a complex behavioural process strongly influenced by: the environments in which people live healthcare providers’ practice how healthcare systems deliver care

Adherence is related to: people’s knowledge and beliefs about their illness their motivation to manage it having confidence in their ability to engage in illness-management behaviours

Adherence is related to: their expectations regarding the outcome of treatment and the consequences of poor adherence. As a consequence medicines-taking behaviour is likely to change over time Necessity Concerns

Common interventions Educating patient on the medicine to increase their knowledge Simplifying the regimen Making it easier to remember to use the medicine (physical aids and reminders) But these interventions don’t address many patient issues

NICE guidance Medicines Adherence – Involving patients in decisions about prescribed medicines and supporting adherence (Clinical Guideline 76) Involve patients in decisions about medicines Support adherence Review medicines Improve communication between healthcare professionals

Applying this in practice requires: Healthcare professionals need to consider perceptual and practical factors that influence the patient’s motivation and ability to adhere to agreed treatment Applying this in practice requires: recognition that non-adherence is common a patient-centred approach a no‑blame approach identification of specific perceptual and practical barriers for each patient a frank and open discussion

Improve communication Adapt your consultation style to each patient’s needs Establish: the best way to communicate with each patient and consider using communication aids the level of involvement the patient wants Ask open-ended questions Encourage patients to ask questions

Increase patient involvement Increase patient involvement by: clearly explaining the condition and the pros and cons of treatment clarifying what the patient hopes the treatment will achieve talking and listening to the patient (note any non verbal cues) rather than making assumptions about patients’ preferences about treatment

Increase patient involvement Help patients make decisions based on likely benefits and risks rather than misconceptions Accept that patients: may have different views from healthcare professionals about risks, benefits and side effects have the right to decide not to take a medicine if they have the capacity to, and have the information to make an informed decision

Understand the patient’s perspective Patients sometimes make decisions about medicines based on their understanding of their condition and possible treatments, their view of their need for the medicine and their concerns. You can improve your understanding by asking patients: - what they know, believe and understand about their medicines and their need for a particular treatment - about any general or specific concerns whenever you prescribe, dispense or review medicines

Provide information Before prescribing, offer patients clear, relevant information on their condition and the possible treatments Discuss information rather than just presenting it Check patients have any information they wish when medicines are dispensed Do not assume that PILs will meet each patient’s needs Offer individualised information that is easy to understand and free from jargon

Assess adherence Routinely assess adherence in a non-judgemental way whenever you prescribe, dispense and review medicines Make it easier for patients to report non‑adherence Consider using records to identify potential non‑adherence and patients needing support

Interventions to increase adherence Discuss whether non-adherence is because of a patient’s beliefs and concerns or practical problems Together consider options for support Only use interventions to overcome practical problems if there is a specific need If side effects are a problem: discuss the benefits of treatment suggest ways of managing side effects consider adjusting the dosage or other strategies

Review medicines At agreed intervals, review patients’ knowledge, understanding and concerns about medicines and whether they think they still need the medicine Offer repeat information and review, especially when treating long-term conditions with multiple medicines Ask about adherence when reviewing medicines

Improve communication between healthcare professionals Those involved in prescribing, dispensing or reviewing medicines should ensure robust processes are in place for communicating with other healthcare professionals involved in the patient’s care When reviewing medicines inform the prescriber of the review and its outcome

Improve communication between healthcare professionals Transfer between services Improve communication between healthcare professionals Provide a written report for patients and subsequent care providers containing: the patient's diagnosis medicines the patient should be taking new medicines that were started medicines that were stopped, with reasons which medicines should be continued after transfer and for how long adverse reactions and allergies potential difficulties with adherence and actions taken

What can community pharmacy do? Targeted Medicines Use Reviews Repeat dispensing Use of appropriate compliance aids New Medicine Service

References/further reading Targeting Adherence – Improving patient outcomes in Europe through community pharmacists’ intervention. PGEU 2008 http://www.pgeu.org/Portals/6/documents/2008/Publications/08.05.13E%20Targeting%20adherence.pdf Medicines Adherence. NICE clinical guideline 76 www.nice.org.uk/CG76 Thinking outside the pillbox. New England Healthcare Institute http://www.nehi.net/publications/44/thinking_outside_the_pillbox_a_systemwide_approach_to_improving_patient_medication_adherence_for_chronic_disease

References/further reading Patients’ problems with new medication for chronic conditions N Barber et al Qual Saf Health Care 2004;13:172-175 Patient-centred advice is effective in improving adherence to medicines S Clifford et al Pharm World Sci 2006;28:165-170 The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines R Elliott et al Pharm World Sci 2008;30:17-23 Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: Application of the Necessity-Concerns Framework S Clifford et al Journal of Psychosomatic Research 2008;64:41-46